Bioxyne Limited (ASX:BXN – Get Free Report) insider Anthony (Tony) Ho sold 4,000,000 shares of the business’s stock in a transaction dated Monday, December 15th. The shares were sold at an average price of A$0.04, for a total value of A$172,000.00.
Anthony (Tony) Ho also recently made the following trade(s):
- On Monday, December 15th, Anthony (Tony) Ho sold 2,000,000 shares of Bioxyne stock. The shares were sold at an average price of A$0.04, for a total transaction of A$86,000.00.
Bioxyne Stock Performance
The firm has a market cap of $96.31 million, a PE ratio of -7.22 and a beta of 0.78. The company has a current ratio of 1.92, a quick ratio of 2.30 and a debt-to-equity ratio of 18.68.
About Bioxyne
Bioxyne Limited, a life sciences and consumer health products company, manufactures and distributes consumer health products, patented probiotics, health supplements, therapeutic goods, and alternative medicines in the United Kingdom, Japan, Europe, and Australia. The company manufactures, commercializes, and distributes plant-based wellness products and supplements, including cannabinoids, cannabis extracts, vitamins, manuka honey, skin care products, and mushroom complexes.
Recommended Stories
- Five stocks we like better than Bioxyne
- What is a buyback in stocks? A comprehensive guide for investors
- Massive Breakout in Industrials: 3 Must-Watch Stocks Now
- How to Buy Gold Stock and Invest in Gold
- 3 Tech Stocks Down Over 60%—Which One Is Worth Buying?
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- 25 Years Later, Cisco Finally Recovers From the Dot-Com Crash
Receive News & Ratings for Bioxyne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioxyne and related companies with MarketBeat.com's FREE daily email newsletter.
